Search - tctmd.com

Displaying 41 - 55 of 55

Sort: Relevancy | Date

News Industry News

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

March 24, 2014

News Daily News

初期研究显示利伐沙班拮抗剂安全、有效

December 30, 2013

News Daily News

Rivaroxaban Antidote Appears Safe, Effective in Early Study

December 30, 2013

News Daily News

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

December 30, 2013

News Daily News

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Jason Kahn

October 04, 2013

News Daily News

Meta-analysis Suggests Vitamin C Protective Against Acute Kidney Injury

Caitlin E. Cox

September 13, 2013

News Daily News

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

L.A. McKeown

April 26, 2013

News Conference News TCT 2012

Stroke Prevention Strategies Discussed

October 26, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

News Daily News

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

August 14, 2012

News Daily News

RE-LY: Dabigatran Shortens Drug Interruption with No Increased Bleeding

Jason Kahn

June 22, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Daily News

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

L.A. McKeown

September 13, 2011

News Daily News

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Caitlin E. Cox

August 10, 2011

News Daily News

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

Kim Dalton

September 03, 2009

Advertisement

New Pradaxa® (dabigatran etexilate mesylate) Data to be Presented at American College of Cardiology Scientific Session (ACC.14)

初期研究显示利伐沙班拮抗剂安全、有效

Rivaroxaban Antidote Appears Safe, Effective in Early Study

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Meta-analysis Suggests Vitamin C Protective Against Acute Kidney Injury

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

Stroke Prevention Strategies Discussed

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

RE-LY: Dabigatran Shortens Drug Interruption with No Increased Bleeding

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content